A Multicenter, Randomized Trial of Prophylactic Fluconazole in Preterm Neonates

Abstract
Invasive candida infections are a major cause of morbidity and mortality in preterm infants. We performed a multicenter, randomized, double-blind, placebo-controlled trial of fluconazole for the prevention of fungal colonization and infection in very-low-birth-weight neonates.